TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Biovica International AB
Closing information (x1000 DKK)
| Closing information | 2023/04 (consolidated) | 2022/04 (consolidated) | 2021/04 (consolidated) |
| Turnover |
1,476
|
1,521 | |
| Financial expenses |
57
|
44 | |
| Earnings before taxes |
-43,297
|
-28,848 | |
| EBITDA |
-38,729
|
-24,932 | |
| Total assets |
109,435
|
141,105 | |
| Current assets |
68,501
|
107,864 | |
| Current liabilities |
11,615
|
6,295 | |
| Equity capital |
89,557
|
133,789 | |
| - share capital |
1,371
|
1,151 | |
| Employees (average) |
31
|
25
|
20 |
Financial ratios
| Fiscal year | 2023/04 (consolidated) | 2022/04 (consolidated) | 2021/04 (consolidated) |
| Solvency |
81.8%
|
94.8% | |
| Turnover per employee |
59
|
76 | |
| Profit as a percentage of turnover |
-2933.4%
|
-1896.6% | |
| Return on assets (ROA) |
-39.5%
|
-20.4% | |
| Current ratio |
589.8%
|
1713.5% | |
| Return on equity (ROE) |
-48.3%
|
-21.6% | |
| Change turnover |
-23
|
297 | |
| Change turnover % |
65%
|
-2%
|
24% |
| Chg. No. of employees |
6
|
5
|
3 |
| Chg. No. of employees % |
24%
|
25%
|
18% |
Total value of public sale
| Fiscal year | 2023/04 (consolidated) | 2022/04 (consolidated) | 2021/04 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.